Cargando…
Advances in drug resistance of triple negative breast cancer caused by pregnane X receptor
Breast cancer is the most common malignancy in women worldwide. Triple-negative breast cancer (TNBC), refers breast cancer negative for estrogen receptor, progesterone receptor and human epidermal growth factor receptor 2, characterized by high drug resistance, high metastasis and high recurrence, t...
Autores principales: | Rao, Zhou-Zhou, Tang, Zhong-Wen, Wen, Jie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10523191/ https://www.ncbi.nlm.nih.gov/pubmed/37771631 http://dx.doi.org/10.5306/wjco.v14.i9.335 |
Ejemplares similares
-
Recent advances in triple negative breast cancer: the immunotherapy era
por: Marra, Antonio, et al.
Publicado: (2019) -
Overview of recent advances in metastatic triple negative breast cancer
por: O'Reilly, David, et al.
Publicado: (2021) -
Immunotherapy in triple-negative breast cancer: A literature review and new advances
por: Valencia, Guillermo Arturo, et al.
Publicado: (2022) -
Curcuma zedoaria petroleum ether extract reverses the resistance of triple-negative breast cancer to docetaxel via pregnane X receptor
por: Qiao, En-Qi, et al.
Publicado: (2021) -
Effect of pregnane X receptor expression on drug resistance in breast cancer
por: QIAO, EN-QI, et al.
Publicado: (2014)